Transforming growth factor beta signaling in adult cardiovascular diseases and repair

Thomas Doetschman1, Joey V Barnett, Raymond B Runyan

  • 1BIO5 Institute, University of Arizona, Tucson, AZ 85724, USA.

Cell and Tissue Research
|September 29, 2011
PubMed

Insights

Adults with congenital heart disease are a growing population facing unique cardiovascular issues. Understanding transforming growth factor beta (TGFβ) signaling is key to improving treatments for these complex adult cardiovascular diseases.

Area of Science:

  • Cardiovascular Science
  • Developmental Biology
  • Genetics

Background:

  • Advances in medicine allow more children with congenital heart disease (CHD) to survive into adulthood.
  • Adults with CHD represent the largest demographic for adult cardiovascular diseases, presenting complex and often poorly understood conditions.
  • These conditions include untreated childhood defects, post-surgical complications, exercise intolerance, and age-related degenerative changes.

Purpose of the Study:

  • To explore the role of transforming growth factor beta (TGFβ) signaling pathways in the development and progression of adult cardiovascular diseases.
  • To summarize current knowledge on specific TGFβ ligand, receptor, and effector genes implicated in cardiovascular pathologies.
  • To highlight the need for a deeper understanding of TGFβ signaling in cardiovascular disease and repair for improved clinical interventions.

Main Methods:

  • Review and summarization of existing scientific literature on TGFβ signaling pathways.
  • Focus on a subset of TGFβ pathway genes known to be dysregulated in cardiovascular diseases.
  • Analysis of the developmental basis of adult cardiovascular disease and its connection to TGFβ signaling.

Main Results:

  • TGFβ signaling pathways, crucial for cardiovascular development, are implicated in the homeostatic, repair, and stress responses in adult cardiovascular diseases.
  • Dysregulation of specific TGFβ pathway genes is linked to cardiovascular diseases and adult pathologies.
  • Current understanding of adult cardiovascular diseases in the CHD population is limited, necessitating further research.

Conclusions:

  • A comprehensive understanding of the TGFβ signaling network in cardiovascular disease and repair is essential for advancing research in elderly patients.
  • Investigating TGFβ pathways can lead to improved genetic and physiological insights into cardiovascular diseases.
  • This knowledge is critical for developing more effective clinical interventions for adults with complex cardiovascular conditions originating from childhood CHD.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...